High-yield of CD34+ cells with bortezomib-basedmobilization regimen is associated with specific genomic expression patterns, decrease in SDF-1 plasma levels and up-regulation of CXCR4 in multiple myeloma (MM) patients.

Title	High-yield of CD34+ cells with bortezomib-basedmobilization regimen is associated with specific genomic expression patterns, decrease in SDF-1 plasma levels and up-regulation of CXCR4 in multiple myeloma (MM) patients.
Publication Type	Presentation
Year of Publication	2011
Authors	Ward M.M., Mark T., Manco M., Stern J., O'Loughlin J., Shore T.B., Pearse R.N., Jayabalan D., Skerrett D., Chen-King S., Lane M.E., Niesvizky R.
DOI	10.1016/j.bbmt.2010.12.083